Public health: hepatitis C.
Do you support it?
Want to know if it passes?
We'll email you when AB 383 moves — a committee vote, a floor vote, or a signature. Nothing else.
Free forever · unsubscribe in one click.
Your answer was recorded either way.
Which district are you in?
Your ZIP is all we need to match you to your own representatives — so we can tell you how they voted on AB 383.
You're tracking AB 383
We'll email you the moment it moves.
AB 383 — Public health: hepatitis C.
Last action — From committee: Filed with the Chief Clerk pursuant to Joint Rule 56.
No card. One bill, free forever — alerts when it moves.
-
✓Introduced
-
2In Committee
-
3Passed Assembly
-
4Passed Senate
-
5To Executive
-
6Enacted
This bill died with 2015-2016 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.
Summary
Existing law, the Hepatitis C Education, Screening, and Treatment Act, sets forth provisions pertaining to education and outreach related to hepatitis C, as specified. The act sets forth findings, declarations, and the intent of the Legislature with regard to these provisions, and requires the Director of Public Health to, among other things, develop and implement a public education and outreach program to raise awareness of the hepatitis C virus aimed at high-risk groups, physician's offices, health care workers, and health care facilities. This bill would, until January 1, 2023, require a primary care clinic to offer each patient who receives primary care services in the clinic, and conduct upon agreement, a hepatitis C screening or diagnostic test, as specified, and would specify the manner in which the results of that test are provided. These requirements would not apply if the patient has taken a hepatitis C screening or diagnostic test, if the patient has been offered a hepatitis C screening or diagnostic test and declined the test within the primary care clinic within the previous 12 months, or to an individual receiving primary care services in a hospital or emergency room setting. The bill would add additional findings and declarations, including that hepatitis C is the most common bloodborne pathogen in the United States, and is a leading cause of complications from chronic liver disease.
Bill Text
- Amended 04/30/15 - Amended Assembly Current pdf April 30, 2015
- Amended 03/26/15 - Amended Assembly pdf March 26, 2015
- Introduced 02/18/15 - Introduced pdf February 18, 2015
- AB383 View text html
Action History
-
From committee: Filed with the Chief Clerk pursuant to Joint Rule 56.
-
Died pursuant to Article IV, Sec. 10(c) of the Constitution.
-
In committee: Held under submission.
-
In committee: Set, first hearing. Referred to APPR. suspense file.
-
Re-referred to Com. on APPR.
-
Read second time and amended.
-
From committee: Amend, and do pass as amended and re-refer to Com. on APPR. (Ayes 19. Noes 0.) (April 28).
-
In committee: Set, first hearing. Hearing canceled at the request of author.
-
Re-referred to Com. on HEALTH.
-
From committee chair, with author's amendments: Amend, and re-refer to Com. on HEALTH. Read second time and amended.
-
Referred to Com. on HEALTH.
-
From printer. May be heard in committee March 21.
-
Read first time. To print.
Sponsors
- Mike A. Gipson · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 121 not signed on
Sponsors (1)
- Gipson, Mike A. Democratic
Co-sponsors (0)
None.
Not signed on (121)
121 members have not signed on to this bill.
Show all 121 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Votes
| Party | Yea | Nay | Present | Not Voting |
|---|---|---|---|---|
| Democratic | 1 | 0 | 0 | 0 |
| Republican | 2 | 0 | 0 | 0 |
| Unaffiliated | 16 | 0 | 0 | 0 |
| Total | 19 | 0 | 0 | 0 |
| % of votes cast | 100% | 0% | 0% | 0% |
How each member voted (19)
| Member | Party | Vote |
|---|---|---|
| Maienschein | — | Yea |
| Rodriguez | — | Yea |
| Santiago | — | Yea |
| Waldron | — | Yea |
| Bonilla | — | Yea |
| Gomez | — | Yea |
| Burke | — | Yea |
| Chiu | — | Yea |
| Chávez | — | Yea |
| Nazarian | — | Yea |
| Ridley-Thomas | — | Yea |
| Steinorth | — | Yea |
| Thurmond | — | Yea |
| Wood | — | Yea |
| Gonzalez | — | Yea |
| Roger Hernández | — | Yea |
| Bonta, Mia | Democratic | Yea |
| Lackey, Tom | Republican | Yea |
| Patterson, Joe | Republican | Yea |
Subjects
Frequently asked questions
- What does AB 383 do?
- Existing law, the Hepatitis C Education, Screening, and Treatment Act, sets forth provisions pertaining to education and outreach related to hepatitis C, as specified. The act sets forth findings, declarations, and the intent of the Legislature with regard to these provisions, and requires the Director of Public Health to, among other things, develop and implement a public education and outreach program to raise awareness of the hepatitis C virus aimed at high-risk groups, physician's offices, health care workers, and health care facilities. This bill would, until January 1, 2023, require a primary care clinic to offer each patient who receives primary care services in the clinic, and conduct upon agreement, a hepatitis C screening or diagnostic test, as specified, and would specify the manner in which the results of that test are provided. These requirements would not apply if the patient has taken a hepatitis C screening or diagnostic test, if the patient has been offered a hepatitis C screening or diagnostic test and declined the test within the primary care clinic within the previous 12 months, or to an individual receiving primary care services in a hospital or emergency room setting. The bill would add additional findings and declarations, including that hepatitis C is the most common bloodborne pathogen in the United States, and is a leading cause of complications from chronic liver disease.
- Who sponsors AB 383?
- AB 383 is sponsored by Gipson, Mike A. (Democratic).
- What is the current status of AB 383?
- This bill died with 2015-2016 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
- Where can I track AB 383?
- Track AB 383 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on AB 383
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of AB 383
Last checked for changes 3 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →